Browse By Assay Result Page of OvirusTdb

The total number record retrieved from this search are 100. Click on ID to see further detail.
IDVirus nameVirus strainVirus genome typeVirus familyVirus genome modificationVirus aloneVirus in combination with drug/radiationImmune gene insertion in viral genomeSource of cell lineOrigin of cell lineCell lineConcentration of cell lineIn-vitro toxicityAssayIn-vitro virus concentrationIn-vitro resultModel organismIn-vivo virus concentrationIn-vivo toxicityIn-vivo resultMode of deliveryPathway inducedImmunogenic effectClinical trialPMID
OV_2542AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI80% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2543AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI70% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2544AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHep3BNANAMTT assay10 MOI60% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2545AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI100% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2546AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI80% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2547AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI40% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2548AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell linePLCNANAMTT assay10 MOI10% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2549AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI90% cells viable after day 1NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2550AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI70% cells viable after day 2NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2551AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI50% cells viable after day 3NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2552AdenovirusAD55-ApoptinDNAAdenoviridaeDeletion of E1B gene and insertion of Apoptin geneYesNoNoATCCHuman hepatocellular carcinoma cell lineHuh-7NANAMTT assay10 MOI30% cells viable after day 4NoNoNA No responseNAInduction of apotosis as measured by TUNEL assayNANA22321574
OV_2554AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI90.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2555AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI70.3% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2556AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI56.2% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2557AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI25.3% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2558AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI88.3% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2559AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI64% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2560AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI35.2% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2561AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHepG21000 cellsNAMTT assay10 MOI17.7% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2562AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI88.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2563AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI72.3% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2564AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI58% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2565AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI28% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2566AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI84.3% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2567AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI66.2% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2568AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI54.5% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2569AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineMHCC97L1000 cellsNAMTT assay10 MOI24% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2570AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI90% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2571AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI72.5% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2572AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI50.2% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2573AdenovirusSG600-IL-24DNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 geneYesNoVirus expressing IL-24 geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI28.2% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2574AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI87.2% cell survival after 24 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2575AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI68% cell survival after 48 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2576AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI45% cell survival after 72 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2577AdenovirusSG600-IL-24+IFNDNAAdenoviridaeDeletion of E1B gene and insertion of IL-24 gene and addition of INYesNoVirus expressing IL-24 gene and IFN geneATCCHuman hepatocellular carcinoma cell lineHCCLM31000 cellsNAMTT assay10 MOI25% cell survival after 96 hoursNoNoNA No responseNACombined therapy increases STAT1, SOCS1 and apoptosisCombined therapy decreases expression of MMP-2, XIAP,OPN and VEGFNA22569271
OV_2579AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay0.1 MOI100% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2580AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay1 MOI100% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2581AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay10 MOI50% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2582AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay100 MOI20% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2583AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay1000 MOI10% cell survivalNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2584AdenovirusCNHK600-IL24DNAAdenoviridaeDeletion of E1B gene and addition of IL-24 geneYesNoVirus expressing IL-24 geneShanghai laboratory animal center, ChinaHuman breast cancer cell lineMDA-MB-2311.0E+5 cells per wellNAMTT assay10000 MOIAll cells are deadNoNoNA No responseNAInduction of apoptosis in cancerNANA22640485
OV_2588AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell lineHepG25.0E+4 cells per wellNAMTT assay10 MOI10% cells are viable after 4 daysNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2589AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell lineHuh-75.0E+4 cells per wellNAMTT assay10 MOI10% cells are viable after 4 daysNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2590AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell lineSMMC77215.0E+4 cells per wellNAMTT assay10 MOI10% cells are viable after 4 daysNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2591AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell linePLC5.0E+4 cells per wellNAMTT assay10 MOI10% cells are viable after 4 daysNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2592AdenovirusAd.enAFP-E1A-delta-E1B-IL-24DNAAdenoviridaeDeletion of E1A, E1B and addition of AFP and IL-24YesNoVirus expressing IL-24 geneATCCHuman liver cancer cell lineHep3B5.0E+4 cells per wellNAMTT assay10 MOI10% cells are viable after 4 daysNoNoNA No responseNAInduction of apoptosis in cancerUpregulation of GADD34NA22790965
OV_2606AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay1 MOI5% cell growth suppression after day 1NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2607AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay1 MOI10% cell growth suppression after day 2NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2608AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay1 MOI20% cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2609AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay1 MOI30% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2610AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay10 MOI40% cell growth suppression after day 1NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2611AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay10 MOI50% cell growth suppression after day 2NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2612AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay10 MOI60% cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2613AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay10 MOI70% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2614AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay100 MOI50% cell growth suppression after day 1NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2615AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay100 MOI70% cell growth suppression after day 2NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2616AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay100 MOI100% cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2617AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineSGC-79011.0E+4 cells per wellNAMTT assay100 MOI100% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2618AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay1 MOINo cell growth suppression after day 1NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2619AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay1 MOI10% cell growth suppression after day 2NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2620AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay1 MOI10% cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2621AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay1 MOI20% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2622AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay10 MOI10% cell growth suppression after day 1NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2623AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay10 MOI10% cell growth suppression after day 2NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2624AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay10 MOINo cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2625AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay10 MOI15% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2626AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay100 MOI20% cell growth suppression after day 1NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2627AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay100 MOI20% cell growth suppression after day 2NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2628AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay100 MOI5% cell growth suppression after day 3NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2629AdenovirusAd-hTERT-E1a-ApoptinDNAAdenoviridaeAddition of E1a and apoptin before hTERT promoterYesNoNoType culture collection of chines academy, shanghaiHuman gastric cancer cell lineGES-11.0E+4 cells per wellNAMTT assay100 MOI15% cell growth suppression after day 4NoNoNA No responseNAInduction of apoptosis in cancerNANA22842823
OV_2632AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI80% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2633AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2634AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI90% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2635AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseYesNoNoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2636AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI70% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2637AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI30% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2638AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2639AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI20% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2640AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2641AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI30% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2642AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI60% cell survival after 3 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2643AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI20% cell survival after 6 daysNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2644AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.001 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2645AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.01 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2646AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2647AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI50% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2648AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay10 MOI40% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2649AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.001 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2650AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.01 MOI70% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2651AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay0.1 MOI40% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2652AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay1 MOI20% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2653AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMDA-MB-2311.0E+4 cells per wellNAMTT assay10 MOI10% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2654AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.001 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2655AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.01 MOI80% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2656AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.1 MOI60% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2657AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay1 MOI50% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2658AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug Bvdu (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay10 MOI30% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2659AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.001 MOI70% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2660AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.01 MOI70% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515
OV_2661AdenovirusSG500-dNKDNAAdenoviridaeAddition of deoxyribonucleoside kinaseNoVirus in combination with drug dFdC (1 micromolar)NoShanghai cell collectionHuman breast cancer cell lineMCF-71.0E+4 cells per wellNAMTT assay0.1 MOI30% cell survivalNoNoNA No responseNACombination of drug and virus increase the apoptosis processNANA23000515